Cite
HARVARD Citation
Yildiz Pekoz, A. et al. (2022). Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis. Drug delivery. pp. 2846-2854. [Online].